We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

62 hedge funds and large institutions have $485M invested in Portola Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+62
Holders Change %
–
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
62
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$104M +$84.1M +4,233,568 New
MAM
2
MPM Asset Management
Massachusetts
$60M +$48.5M +2,441,344 New
BCPEM
3
Bain Capital Public Equity Management
Massachusetts
$53.7M +$43.4M +2,185,013 New
A
4
Abingworth
United Kingdom
$30.5M +$24.7M +1,240,917 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$27.9M +$22.5M +1,134,038 New
Jennison Associates
6
Jennison Associates
New York
$26.7M +$21.6M +1,085,774 New
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$18.9M +$15.5M +777,779 New
FAM
8
Fred Alger Management
New York
$17.2M +$13.9M +698,169 New
Fidelity Investments
9
Fidelity Investments
Massachusetts
$15.8M +$12.8M +644,600 New
DM
10
Deerfield Management
New York
$13M +$10.5M +527,410 New
O
11
OrbiMed
New York
$11.8M +$9.55M +480,319 New
Franklin Resources
12
Franklin Resources
California
$11.6M +$9.38M +471,901 New
BBA
13
Baker Bros. Advisors
New York
$9.83M +$7.95M +399,914 New
Wellington Management Group
14
Wellington Management Group
Massachusetts
$9.51M +$7.69M +386,900 New
BI
15
BVF Inc
California
$7.51M +$6.08M +305,786 New
EA
16
Emerald Advisers
Pennsylvania
$6.56M +$5.3M +266,810 New
BCM
17
BBT Capital Management
Texas
$5.78M +$4.68M +235,335 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$5.43M +$4.39M +221,000 New
BFA
19
BlackRock Fund Advisors
California
$5.39M +$4.36M +219,368 New
Goldman Sachs
20
Goldman Sachs
New York
$5.26M +$4.26M +214,226 New
BIT
21
BlackRock Institutional Trust
California
$5.1M +$4.13M +207,642 New
Millennium Management
22
Millennium Management
New York
$4.94M +$4M +201,123 New
PI
23
Putnam Investments
Massachusetts
$4.91M +$3.98M +200,000 New
EMFAT
24
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.42M +$2.77M +139,349 New
ICAP
25
Independence Capital Asset Partners
Colorado
$2.46M +$1.99M +100,025 New
1
2 3

PTLA Hedge Fund Activity: Q2 2013 in Review

62 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q2 2013, worth a combined $485M.

Buyers outnumbered sellers: 62 funds opened new PTLA positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.

  • 62 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $485M of Portola Pharmaceuticals, Inc. stock for Q2 2013.
  • 62 funds opened new Portola Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +62 holders.

Based on aggregated 13F filings for Q2 2013.